StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$601.55K
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
-$20.79K
EPS, diluted
$0.00
Book value per share
-$0.00
Diluted shares
84M

Trading

Previous close
$0.01
Open
$0.01
Day's range
$0.01 – $0.01
Volume
160,000
Average volume (20 days)
57,767

Market cap history

Month-end market cap since 2014, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodNUMDS&P 500DifferenceNUMD per yearS&P 500 per year
1 month-68.7%+0.6%−69.3 pts
3 months-60.9%+3.4%−64.2 pts
Year to date-58.3%+13.3%−71.6 pts
1 year-76.0%+16.6%−92.6 pts
3 years-67.3%+86.4%−153.7 pts-31.1%+23.1%
5 years-89.9%+81.9%−171.7 pts-36.8%+12.7%
10 years-98.4%+318.9%−417.2 pts-33.7%+15.4%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

–

Operating income

-$55.54K

Net income

-$20.79K

EPS, diluted

$0.00

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Nu-Med Plus filed with the SEC as exhibits to Form 8-K or 6-K

About Nu-Med Plus

Gold and Silver Ores

Nu-Med Plus, Inc. is a medical device company focused on the design, development, and commercialization of technologies utilizing nitric oxide in the medical field. The company develops proprietary formulations to generate nitric oxide gas on demand, eliminating the need for compressed gas cylinders. Its product pipeline includes hospital nitric oxide delivery devices for intensive care ventilator patients, clinical delivery systems for doctor offices and clinics, mobile rechargeable devices for inhalation therapy, disposable treatment units, and gas dilution systems for research applications. The company targets applications across hospital intensive care units, outpatient clinics, and research laboratories.

Company profile, executives and history

Nu-Med Plus stock: common questions

What is Nu-Med Plus's stock price?

NUMD closed at $0.01 on Oct 19, 2026, down 8.16% on the day.

What is Nu-Med Plus's market cap?

Nu-Med Plus was worth $601.55K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is NUMD's P/E ratio?

Nu-Med Plus lost money over the twelve months to Jun 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.

Does Nu-Med Plus pay a dividend?

No. Nu-Med Plus has not paid a cash dividend over the last twelve months.

How has NUMD stock performed over the past year?

Including dividends, NUMD returned -76.0% over the past year, against +16.6% for the S&P 500.

Who are Nu-Med Plus's competitors?

Companies most similar to Nu-Med Plus by business, industry and size include XAIR, STME, QTEX, MODD, AURX.

See a number that looks wrong?